PD-1 ligands, negative regulators for activation of naïve, memory, and recently activated human CD4+ T cells
- 1 August 2004
- journal article
- Published by Elsevier in Cellular Immunology
- Vol. 230 (2) , 89-98
- https://doi.org/10.1016/j.cellimm.2004.09.004
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Association of a programmed death 1 gene polymorphism with the development of rheumatoid arthritis, but not systemic lupus erythematosusArthritis & Rheumatism, 2004
- Cross-linking the B7 Family Molecule B7-DC Directly Activates Immune Functions of Dendritic CellsThe Journal of Experimental Medicine, 2002
- A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humansNature Genetics, 2002
- The B7 Family of Ligands and Its Receptors: New Pathways for Costimulation and Inhibition of Immune ResponsesAnnual Review of Immunology, 2002
- PD-1:PD-L inhibitory pathway affects both CD4+ and CD8+ T cells and is overcome by IL-2European Journal of Immunology, 2002
- The B7–CD28 superfamilyNature Reviews Immunology, 2002
- Autoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient MiceScience, 2001
- Activation-Induced Expression of Human Programmed Death-1 Gene in T-LymphocytesExperimental Cell Research, 1997
- The coexpression of CD45RA and CD45RO isoforms on T cells during the S/G2/M stages of cell cycleCellular Immunology, 1991
- T-cell recognition of an immuno-dominant myelin basic protein epitope in multiple sclerosisNature, 1990